Eating behavior in laparoscopic sleeve gastrectomy: Correlation between plasma ghrelin levels and hunger

European Surgery - Acta Chirurgica Austriaca

Volumn 40, Issue 3, 2008, Pages 120-124

  Langer, F B ^a   Bohdjalian, A ^a   Shakeri Manesch, S ^a   Zacherl, J ^a   Riener, R ^b   Schindler, K ^b   Ludvik, B ^b   Prager, Gerhard ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Eating behavior; Ghrelin; Hunger; Sleeve gastrectomy; TFEQ

Indexed keywords

GHRELIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; FEEDING BEHAVIOR; FEMALE; GASTRECTOMY; HUMAN; HUNGER; MALE; OBESITY; OUTCOME ASSESSMENT;

EID: 46749083111     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10353-008-0406-0     Document Type: Article

References (48)

1. Buchwald H, Avidor Y, Braunwald E Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Jama 2004;292:1724-37.
2. Raftopoulos I, Ercole J, Udekwu AO, Luketich JD, Courcoulas AP. Outcomes of Roux-en-Y gastric bypass stratified by a body mass index of 70 kg/m2: a comparative analysis of 825 procedures. J Gastrointest Surg 2005;9:44-52; discussion -3.
3. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000;10:233-239.
4. Zinzindohoue F, Chevallier JM, Douard R, Elian N, Ferraz JM, Blanche JP, Berta JL, Altman JJ, Safran D, Cugnenc PH. Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity: prospective study of 500 consecutive patients. Ann Surg 2003;237:1-9.
5. Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern GJ. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-51.
6. Langer FB, Bohdjalian A, Hoda A, Silberhumer G, Felberbauer FX, Rasoul-Rockenschaub S, Zacherl J, Wenzl E, Prager G. Early results of laparoscopic adjustable gastric banding using the new low-pressure Soft-Gastric-Band. Eur Surg 2004;36: 345-9.
7. Hell E, Miller KA, Moorehead MK, Norman S. Evaluation of health status and quality of life after bariatric surgery: comparison of standard Roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding. Obes Surg 2000;10:214-9.
8. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002;184:51S-4S.
9. Arcila D, Velazquez D, Gamino R, Sierra M, Salin-Pascual R, Gonzalez-Barranco J, Herrera MF. Quality of life in bariatric surgery. Obes Surg 2002;12:661-5.
10. Weiner R, Blanco-Engert R, Weiner S, Matkowitz R, Schaefer L, Pomhoff I. Outcome after laparoscopic adjustable gastric banding - 8 years experience. Obes Surg 2003;13:427-34.
11. Kalarchian MA, Marcus MD, Wilson GT, Labouvie EW, Brolin RE, LaMarca LB. Binge eating among gastric bypass patients at long-term follow-up. Obes Surg 2002;12:270-5.
12. Guisado JA, Vaz FJ, Lopez-Ibor JJ Jr, Rubio MA. Eating behavior in morbidly obese patients undergoing gastric surgery: differences between obese people with and without psychiatric disorders. Obes Surg 2001;11:576-80.
13. Burgmer R, Grigutsch K, Zipfel S, Wolf AM, de Zwaan M, Husemann B, Albus C, Senf W, Herpertz S. The influence of eating behavior and eating pathology on weight loss after gastric restriction operations. Obes Surg 2005;15:684-91.
14. Boan J, Kolotkin RL, Westman EC, McMahon RL, Grant JP. Binge eating, quality of life and physical activity improve after Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14:341-8.
15. Schindler K, Prager G, Ballaban, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 2004;34:549-54.
16. Nickel C, Widermann C, Harms D, Leiberich PL, Tritt K, Kettler C, Lahmann C, Rother WK, Loew TH, Nickel MK. Patients with extreme obesity: change in mental symptoms three years after gastric banding. Int J Psychiatry Med 2005;35:109-22.
17. Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 2005;15:1124-8.
18. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004;14:492-7.
19. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 2005;15:1030-3.
20. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003;13:861-4.
21. Melissas J, Koukouraki S, Askoxylakis J, Stathaki M, Daskalakis M, Perisinakis K, Karkavitsas N. Sleeve gastrectomy: a restrictive procedure? Obes Surg 2007;17:57-62.
22. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg Today 2007;37:275-81.
23. Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16:1323-6.
24. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006;16:1450-6.
25. Han SM, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes.Surg 2005;15:1469-75.
26. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
27. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-8.
28. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-5.
29. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50: 1714-9.
30. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024-9.
31. Cohen R, Uzzan B, Bihan H, Khochtali I, Reach G, Catheline JM. Ghrelin Levels and Sleeve Gastrectomy in Super-Super-Obesity. Obes Surg 2005;15:1501-2.
32. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55:615S-9S.
33. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
34. Klingler A. Statistical methods in surgical research - a practical guide. Eur Surg 2004;36:80-4.
35. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg 2003;13:159-60.
36. Pudel V, Westenhöfer J. Fragebogen zum Essverhalten: Handanweisung [Eating Inventory, German version, Manual]. Göttingen: Hogrefe; 1989.
37. Lang T, Hauser R, Buddeberg C, Klaghofer R. Impact of gastric banding on eating behavior and weight. Obes Surg 2002;12:100-7.
38. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337-45.
39. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 2003;138:389-96.
40. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13.
41. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30.
42. St-Pierre DH, Karelis AD, Cianflone K, Conus F, Mignault D, Rabasa-Lhoret R, St-Onge M, Tremblay-Lebeau A, Poehlman ET. Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 2004; 89:5993-7.
43. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 2003;13:17-22.
44. Fruhbeck G, Rotellar F, Hernandez-Lizoain JL, Gil MJ, Gomez-Ambrosi J, Salvador J, Cienfuegos JA. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 2004;14:1208-15.
45. Nijhuis J, van Dielen FM, Buurman WA, Greve JW. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg 2004;14:783-7.
46. Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004;12:346-50.
47. Busetto L, Segato G, De Marchi F, Foletto M, De Luca M, Caniato D, Favretti F, Lise M, Enzi G. Outcome predictors in morbidly obese recipients of an adjustable gastric band. Obes Surg 2002;12:83-92.
48. Larsen JK, van Ramshorst B, Geenen R, Brand N, Stroebe W, van Doornen LJ. Binge eating and its relationship to outcome after laparoscopic adjustable gastric banding. Obes Surg 2004;14:1111-7.